Alzheimers disease is nearing a public emergency with almost 13 million affected. What’s being talked about in the medical community about treatment and new drugs? Join Neurologist, Dr. Lorne Direnfeld hosting this podcast with guest, Dr. Jeffrey Cummings, Professor of Neurology and Psychiatry and the Director of the Mary S Easton Center for Alzheimer’s Disease Research at UCLA. He is also the 2008 winner of the Ronald and Nancy Reagan Research Award. Hear about exciting immuno therapies - antibodies infused by IV - stimulating the removal of toxic amyloid protein from the brain, drugs in preclinical development that promise to inhibit brain cell death and disease modifying therapy that generates the amyloid protein in the brain with a new drug that could be on the market by 2010.